Coherus BioSciences Inc (CHRS) — Cash Flow Reinvestment Rate
Coherus BioSciences Inc (CHRS) has a Cash Flow Reinvestment Rate of 0.02x as of December 2024, reinvesting $542.00K (capex $0.00 plus investments $-542.00K) from operating cash flow of $28.61 Million. Check how high is Coherus BioSciences Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Coherus BioSciences Inc Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Coherus BioSciences Inc across 3 annual periods. Explore Coherus BioSciences Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Coherus BioSciences Inc (2013–2020)
Year-by-year capital reinvestment analysis for Coherus BioSciences Inc. For live market cap and broader valuation context, see Coherus BioSciences Inc (CHRS) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.05x | $7.39 Million | $154.15 Million | $7.23 Million | ▼ -89.6% |
| 2019 | 0.46x | $13.06 Million | $28.36 Million | $12.90 Million | ▲ +1804.8% |
| 2013 | 0.02x | $373.00K | $15.42 Million | $373.00K | — |